---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-009595"
form_type: "8-K"
ticker: "INKT"
cik: "0001840229"
company_name: "MiNK Therapeutics, Inc."
filed_at: "2025-01-21T23:59:59+00:00"
generated_at: "2026-05-27T22:24:43.601866+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# MiNK Therapeutics stockholders approve 1-for-10 reverse stock split effective Jan 28

## Summary
- Special meeting held Jan 17, 2025; 27,582,512 shares voted (quorum).
- Proposal approved with 26,500,274 For, 1,026,255 Against, 56,013 Abstain.
- Reverse split ratio 1-for-10, effective 12:01 a.m. ET on Jan 28, 2025.
- Post-split shares trade under new CUSIP 603693 201 on Nasdaq.
- 39,630,402 shares outstanding pre-split as of record date Dec 16, 2024.

## SEC filing metadata
- accession: 0001193125-25-009595
- form_type: 8-K
- ticker: INKT
- cik: 0001840229
- company_name: MiNK Therapeutics, Inc.
- filed_at: 2025-01-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1840229/000119312525009595/0001193125-25-009595-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1840229/000119312525009595/d926991d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-009595
- JSON: https://secwatch.observer/filing/0001193125-25-009595.json
- Plain text: https://secwatch.observer/filing/0001193125-25-009595.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.